Skip to main content

Advertisement

SpringerLink
Log in

Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy

  • Published:
Neuropsychology Review Aims and scope Submit manuscript

Abstract

Cancer patients report numerous adverse symptoms associated with their disease and treatment including cognitive dysfunction, fatigue, and affective distress. Cognitive dysfunction is ubiquitous in patients with primary central nervous system (CNS) cancer and recent evidence has documented similar deficits in patients with non-CNS cancer as well. Both the cancer itself and treatments including chemotherapy, biological response modifiers, and hormonal therapies have been demonstrated to adversely impact cognitive and neurobehavioral function. Neuroimaging and neurophysiological investigations have likewise revealed alterations in brain function that are helping to account for the nature of these cognitive disorders. Similarly, preclinical animal research is assisting to identify the pathophysiological mechanisms that underlie treatment-related neurotoxicities. The coalescence of multidisciplinary clinical and research efforts hold promise for the development of interventions that may offer neuroprotection in addition to currently available symptomatic therapies and cognitive rehabilitation techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7, 192–201.

    PubMed  CAS  Google Scholar 

  • Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., et al. (2007). Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Research and Treatment [Epub ahead of print].

  • Ahles, T. A., Saykin, A. J., Noll, W. W., et al. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology, 12, 612–619.

    PubMed  Google Scholar 

  • Ahles, T. A., Tope, D. M., Furstenberg, C., Hann, D., & Mills, L. (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology, 14, 1457–62.

    PubMed  CAS  Google Scholar 

  • Alcaraz, A., Rey, C., Concha, A., et al. (2002). Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion. Journal of Toxicology Clinical Toxicology, 40, 557–561.

    PubMed  CAS  Google Scholar 

  • Almeida, O. P., Waterreus, A., Spry, N., et al. (2004). One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology, 29, 1071–1081.

    PubMed  CAS  Google Scholar 

  • Andrykowski, M. A., Altmaier, E. M., Barnett, R. L., et al. (1999). Cognitive dysfunction in adult survivors of allogeneic bone marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Transplant, 6, 269–276.

    Google Scholar 

  • Andrykowski, M. A., Schmitt, F. A., Gregg, M. E., et al. (1992). Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer, 70, 2288–2297.

    PubMed  CAS  Google Scholar 

  • Barton, D., & Loprinzi, C. (2002). Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. Clinical Breast Cancer, 3(Suppl. 3), S121–S127.

    PubMed  Google Scholar 

  • Battaller, L., & Dalmau, J. O. (2004). Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Seminars in Neurology, 24(4), 461–471.

    Google Scholar 

  • Bender, C. M., Yasko, J. M., Kirkwood, J. M., et al. (2000). Cognitive function and quality of life in interferon therapy for melanoma. Clinical Nursing Research, 9, 352–363.

    PubMed  CAS  Google Scholar 

  • Birgegård, G., Aapro, M. S., Bokemeyer, C., et al. (2005). Cancer-related anemia: pathogenesis, prevalence, and treatment. Oncology, 68(Suppl. 1), 3–11.

    PubMed  Google Scholar 

  • Brown, M. S., Stemmer, S. M., Simon, J. H., et al. (1998). White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. American Journal of Neuroradiology, 19, 217–221.

    PubMed  CAS  Google Scholar 

  • Capuron, L., Ravaud, A., Miller, A. H., et al. (2004). Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain, Behavior, and Immunity, 18, 205–213.

    PubMed  CAS  Google Scholar 

  • Castellon, S. A., Ganz, P. A., Bower, J. E., et al. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26, 955–969.

    PubMed  Google Scholar 

  • Chen, Y., Lomnitski, L., Michaelson, D. M., et al. (1997). Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscientist, 80, 1255–1262.

    CAS  Google Scholar 

  • Chen, D., Wu, C. F., Shi, B., & Xu, Y. M. (2002). Tamoxifen and toremifene impair retrieval, but not acquisition, of spatial information processing in mice. Pharmacology, Biochemistry and Behavior, 72, 417–421.

    CAS  Google Scholar 

  • Cherrier, M. M., Rose, A. L., & Higano, C. (2003). The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. Journal of Urology, 170, 1808–1811.

    PubMed  CAS  Google Scholar 

  • Clark, J. W. (1996). Biological response modifiers. Cancer Chemotherapy and Biological Response Modifiers Annual, 16, 239–273.

    CAS  Google Scholar 

  • Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., Wang, X. S., Lee, B.-N. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97(11), 2919–2925.

    PubMed  Google Scholar 

  • Crandall, J., Sakai, Y., Zhang, J., et al. (2004). 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proceedings of the National Academy of Sciences of the United States of America, 101, 5111–5116.

    PubMed  CAS  Google Scholar 

  • Cunningham, R. S. (2003). Anemia in the oncology patient: cognitive function and cancer. Cancer Nursing, 26, 38S–42S.

    PubMed  Google Scholar 

  • Delattre, J. Y., & Posner, J. B. (1995). Neurological complications of chemotherapy and radiation therapy. In M. J. Aminoff (Ed.) Neurology and general medicine 2nd edn (pp. 421–445). New York: Churchill Livingstone.

    Google Scholar 

  • Dieperink, E., Willenbring, M., & Ho, S. B. (2000). Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. American Journal of Psychiatry, 157, 867–876.

    PubMed  CAS  Google Scholar 

  • Dietrich, J., Han, R., Yan, Y., Mayer-Pröschel, M., & Noble, M. (2006). CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology, 5, 22.

    PubMed  Google Scholar 

  • Egan, M. F., Goldberg, T. E., Kolachana, B. S., et al. (2001). Effect of COMT Val108/158 met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 98, 6917–6922.

    PubMed  CAS  Google Scholar 

  • Egan, M. F., Kojima, M., Callicott, J. H., et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257–269.

    PubMed  CAS  Google Scholar 

  • Fann, J. R., Roth-Roemer, S., & Burington, B. E. (2002). Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer, 95, 1971–1981.

    PubMed  Google Scholar 

  • Garcia-Tena, J., Lopez-Andreu, J. A., Ferris, J., et al. (1995). Intrathecal chemotherapy related myeloencephalopathy in a young child with acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 12, 377–385.

    PubMed  CAS  Google Scholar 

  • Gilbert, M. R., & Armstrong, T. S. (1996). Neurotoxicities. In J. Kirkwood, M. Lotze, & J. Yasko (Eds.) Current Cancer Therapeutics 2nd edn (pp. 364–371). Philadelphia: Current Medicine.

    Google Scholar 

  • Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., et al. (2002). Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. British Journal of Urology, 90, 427–432.

    CAS  Google Scholar 

  • Groopman, J. E., & Itri, L. M. (1999). Chemotherapy-induced anemia in adults: incidence and treatment. Journal of the National Cancer Institute, 91, 1616–1634.

    PubMed  CAS  Google Scholar 

  • Harder, H., Cornelissen, J. J., Van Gool, A. R., et al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95, 183–192.

    PubMed  Google Scholar 

  • Harder, H., van Gool, A. R., Cornelissen, J. J., et al. (2005). Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: A comparative study. European Journal of Cancer, 41, 1007–1016.

    PubMed  Google Scholar 

  • Haykin, M. E., Gorman, M., van Hoff, J., et al. (2006). Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity. Journal of Neuro-oncology, 76, 153–157.

    CAS  Google Scholar 

  • Heflin, L. H., Meyerowitz, B. E., Hall, P., et al. (2005). Cancer as a risk factor for long-term cognitive deficits and dementia. Journal of the National Cancer Institute, 97, 854–856.

    PubMed  Google Scholar 

  • Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer, 109, 1905–1913.

    PubMed  CAS  Google Scholar 

  • Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., et al. (2006). Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. Journal of the American Geriatrics Society, 54, 925–931.

    PubMed  Google Scholar 

  • Hurricane Voices Breast Cancer Foundation (2007). Cognitive changes related to cancer Treatment. Retrieved September 15, 2007, from http://www.hurricanevoices.org/today/cognition/hv_cognitive_results.pdf

  • Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawa, Y., Nakano, T., Akechi, T., et al. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109, 146–156.

    PubMed  Google Scholar 

  • Jacobson, N. S., & Truax, P. (1991). Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12–19.

    PubMed  CAS  Google Scholar 

  • Jansen, C., Miakowski, C., Dodd, M., et al. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncology Nursing Forum, 32, 1151–1163.

    PubMed  Google Scholar 

  • Jenkins, V. A., Bloomfield, D. J., Shilling, V. M., et al. (2005). Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU International, 96, 48–53.

    PubMed  CAS  Google Scholar 

  • Jenkins, V., Shilling, V., Deutsch, G., et al. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94, 828–834.

    PubMed  CAS  Google Scholar 

  • Jensen, B. V. (2006). Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. Seminar in Oncology, 33(Suppl. 8), S15–S21.

    CAS  Google Scholar 

  • Johnson, S. A. (2006). Anthracycline-induced cardiotoxicity in adult hematologic malignancies. Seminar in Oncology, 33(Suppl. 8), S22–S27.

    CAS  Google Scholar 

  • Joshi, G., Sultana, R., Tangpong, J., et al. (2005). Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. Free Radical Research, 39, 1147–1154.

    PubMed  CAS  Google Scholar 

  • Keime-Guibert, F., Napolitano, M., & Delattre, J. Y. (1998). Neurological complications of radiotherapy and chemotherapy. Journal of Neurology, 245, 695–708.

    PubMed  CAS  Google Scholar 

  • Kim, Y. A., Chung, H. C., Choi, H. J., et al. (2006). Intermediate dose 5-fluorouracil-induced encephalopathy. Japanese Journal of Clinical Oncology, 36, 55–59.

    PubMed  Google Scholar 

  • Knobf, M. T. (2006). Reproductive and hormonal sequelae of chemotherapy in women. American Journal of Nursing, 106(Suppl. 3), 60–65.

    PubMed  Google Scholar 

  • Krajinovic, M., Robaey, P., Chiasson, S., et al. (2005). Polymorphisms of genes controlling homocysteine levels and IQ score following treatment for childhood ALL. Pharmacogenomics, 6, 293–302.

    PubMed  CAS  Google Scholar 

  • Kreukels, B. P. C., Hamburger, H. L., de Ruiter, M. B., van Dam, F. S. A. M., Ridderinkhof, K. R., Boogerd, W., et al. (2008). ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clinical Neurophysiology, 119, 533–541.

    PubMed  Google Scholar 

  • Largillier, R., Etienne-Grimaldi, M. C., Formento, J. L., et al. (2006). Pharmacogenetics of capecitabine in advanced breast cancer patients. Clinical Cancer Research, 12, 5496–5502.

    PubMed  CAS  Google Scholar 

  • Lee, B. N., Dantzer, R., Langley, K. E., et al. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11, 279–292.

    PubMed  CAS  Google Scholar 

  • Lien, E. A., Wester, K., Lonning, P. E., Solheim, E., & Ueland, P. M. (1991). Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. British Journal of Cancer, 63, 641–645.

    PubMed  CAS  Google Scholar 

  • Linnebank, M., Pels, H., Klecza, N., et al. (2005). MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. Neurology, 64, 912–913.

    PubMed  CAS  Google Scholar 

  • Lipp, H. P. (1999). Neurotoxicity (including sensory toxicity) induced by cytostatics. In H. P. Lipp (Ed.) Anticancer drug toxicity: prevention, management, and clinical pharmacokinetics (pp. 431–453). New York: Marcel Dekker, Inc.

    Google Scholar 

  • Lipshultz, S. E. (2006). Exposure to anthracyclines during childhood causes cardiac injury. Seminar in Oncology, 33(Suppl. 8), 8–14.

    Google Scholar 

  • Madhyastha, S., Somayaji, S. N., Rao, M. S., et al. (2002). Hippocampal brain amines in methotrexate-induced learning and memory deficit. Canadian Journal of Physiology and Pharmacology, 80, 1076–1084.

    PubMed  CAS  Google Scholar 

  • Malek-Ahmadi, P., & Ghandour, E. (2004). Bupropion for treatment of interferon-induced depression. Annals of Pharmacotherapy, 38, 1202–1205.

    PubMed  Google Scholar 

  • Malik, U. R., Makower, D. F., & Wadler, S. (2001). Interferon-mediated fatigue. Cancer, 92(Suppl), 1664–1668.

    PubMed  CAS  Google Scholar 

  • Mayr, N., Zeitlhofer, J., Deecke, L., et al. (1999). Neurological function during long-term therapy with recombinant interferon alpha. Journal of Clinical Neuroscience, 11, 343–348.

    CAS  Google Scholar 

  • McAllister, T. W., Ahles, T. A., Saykin, A. J., et al. (2004). Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments. Current Psychiatry Reports, 6, 364–371.

    PubMed  Google Scholar 

  • McKenna, S. E., Simon, N. G., & Cologer-Clifford, A. (1992). An assessment of agonist/antagonist effects of tamoxifen in the female mouse brain. Hormones and Behaviour, 26, 536–544.

    CAS  Google Scholar 

  • Meyers, C. A., Albitar, M., & Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104, 788–793.

    PubMed  CAS  Google Scholar 

  • Meyers, C. A., Byrne, K. S., & Komaki, R. (1995). Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer, 12, 231–235.

    PubMed  CAS  Google Scholar 

  • Meyers, C. A., Kudelka, A. P., Conrad, C. A., Gelke, C. K., Grove, W., & Pazdur, R. (1997). Neurotoxicity of CI-980, a novel mitotic inhibitor. Clinical Cancer Research, 3, 419–422.

    PubMed  CAS  Google Scholar 

  • Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998). Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. Journal of Clinical Oncology, 16, 2522–2527.

    PubMed  CAS  Google Scholar 

  • Meyers, C. A., & Hess, K. R. (2003). Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression. Neuro-Oncology, 5, 89–95.

    PubMed  Google Scholar 

  • Meyers, C. A., Scheibel, R. S., & Forman, A. D. (1991). Persistent neurotoxicity of systemically administered interferon-alpha. Neurology, 41, 672–676.

    PubMed  CAS  Google Scholar 

  • Meyers, C. A., Weitzner, M., Byrne, K., et al. (1994). Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. Journal Of Clinical Oncology, 12, 820–826.

    PubMed  CAS  Google Scholar 

  • Mihich, E. (2000). Historical overview of biologic response modifiers. Cancer Investigation, 18, 456–466.

    PubMed  CAS  Google Scholar 

  • Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15, 603–630.

    PubMed  CAS  Google Scholar 

  • Molina, J. R., Barton, D. L., & Loprinzi, C. L. (2005). Chemotherapy-induced ovarian failure. Drug Safety, 28, 401–416.

    PubMed  CAS  Google Scholar 

  • Moore, B. D. (2005). Neurocognitive outcomes in survivors of childhood cancer. Journal of Pediatric Psychology, 30, 51–63.

    PubMed  Google Scholar 

  • Mulhern, R. K., Merchant, T. E., Gajjar, A., Reddick, W. E., & Kun, L. E. (2004). Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncology, 5, 399–408.

    PubMed  Google Scholar 

  • Musselman, D. L., Lawson, D. H., Gumnick, J. F., et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alpha. New England Journal of Medicine, 344, 961–966.

    PubMed  CAS  Google Scholar 

  • National Institutes of Health (2003). Biological therapy. Treatments that use your immune system to fight cancer. [Brochure]. NIH Publication No. 03-5406.

  • Okcu, M. F., Selvan, M., Wang, L., et al. (2004). Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clinical Cancer Research, 10, 2618–2625.

    PubMed  CAS  Google Scholar 

  • O’Shaughnessy, J. A., Svetislava, J. V., Holmes, F. A., et al. (2005). Feasibility of quantifying the effects of epoetin alpha therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin Breast Cancer, 5, 439–446.

    Article  PubMed  CAS  Google Scholar 

  • Pavol, M. A., Meyers, C. A., Rexer, J. L., et al. (1995). Pattern of neurobehavioral deficits associated with interferon alpha therapy for leukemia. Neurology, 45, 947–950.

    PubMed  CAS  Google Scholar 

  • Penson, R. T., Kronish, K., Duan, Z., et al. (2000). Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF-alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. International Journal of Gynecological Cancer, 1, 33–41.

    Google Scholar 

  • Peper, M., Steinvorth, S., Schraube, P., et al. (2000). Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. International Journal Radiation Oncology, Biology, Physics, 46, 303–311.

    CAS  Google Scholar 

  • Posner, J. B., & Dalmau, J. O. (2000). Paraneoplastic syndromes of the nervous system. Clinical Chemistry and Laboratory Medicine, 38(2), 117–122.

    PubMed  CAS  Google Scholar 

  • Pusztai, L., Mendoza, T. R., Reuben, J. M., et al. (2004). Changes in plasma level of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine, 25, 94–102.

    PubMed  CAS  Google Scholar 

  • Quinn, C. T., & Kamen, B. A. (1996). A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. Journal of Investigative Medicine, 44, 522–530.

    PubMed  CAS  Google Scholar 

  • Rich, J. B., & Maki, P. (1999). Estrogen, testosterone, and the brain: a review of neuropsychological, aging, and neuroimaging studies. Journal of the International Neuropsychological Society, 6, iii.

    Google Scholar 

  • Roe, C. M., Behrens, M. I., Xiong, C., et al. (2005). Alzheimer disease and cancer. Neurology, 64, 895–898.

    PubMed  CAS  Google Scholar 

  • Salminen, E., Portin, R., Korpela, J., Backman, H., Parvinen, L.-M., Helenius, H., et al. (2003). Androgen deprivation and cognition in prostate cancer. British Journal of Cancer, 89, 971–976.

    PubMed  CAS  Google Scholar 

  • Salminen, E. K., Portin, R. I., Koskinen, A., et al. (2004). Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clinical Cancer Research, 10, 7575–7582.

    PubMed  CAS  Google Scholar 

  • Salminen, E. K., Portin, R. I., Koskinen, A. I., et al. (2005). Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer, 103, 1381–1387.

    PubMed  Google Scholar 

  • Saykin, A. J., Ahles, T. A., & McDonald, B. C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 8, 201–216.

    PubMed  Google Scholar 

  • Schaefer, M., Engelbrecht, M. A., Gut, O., et al. (2002). Interferon alpha (IFN-a) and psychiatric syndromes: a review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 26, 731–746.

    PubMed  CAS  Google Scholar 

  • Schagen, S. B., Muller, M. J., Boogerd, W., et al. (2002). Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective. Clinical Breast Cancer, 3(Suppl), S100–S108.

    PubMed  Google Scholar 

  • Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. (2006). Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98, 1742–1745.

    PubMed  CAS  Google Scholar 

  • Schagen, S. B., van Dam, F. S., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640–650.

    PubMed  CAS  Google Scholar 

  • Scheibel, R. S., Valentine, A. D., O’Brien, S., et al. (2004). Cognitive dysfunction and depression during treatment with interferon alpha and chemotherapy. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 1–7.

    Google Scholar 

  • Schneiderman, B. (2004). Hippocampal volumes smaller in chemotherapy patients. Lancet Oncology, 5, 202.

    PubMed  Google Scholar 

  • Shah, R. R. (2005). Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules. Expert Opinion Drug Safety, 4, 103–128.

    CAS  Google Scholar 

  • Shapiro, C. L., & Recht, A. (2001). Drug therapy—side effects of adjuvant treatment of breast cancer. New England Journal of Medicine, 344, 1997–2008.

    PubMed  CAS  Google Scholar 

  • Sherwin, B. B. (1988). Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology, 13, 345–357.

    PubMed  CAS  Google Scholar 

  • Shilling, V., Jenkins, V., Fallowfield, L., & Howell, A. (2003). The effects of hormone therapy on cognition in breast cancer. Journal of Steroid Biochemistry and Molecular Biology, 86, 405–412.

    PubMed  CAS  Google Scholar 

  • Shilling, V., Jenkins, V., Fallowfield, L., & Howell, A. (2001). The effects of oestrogens and anti-oestrogens on cognition. Breast, 10, 484–491.

    PubMed  CAS  Google Scholar 

  • Shilling, V., Jenkins, V., Morris, R., et al. (2005). The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study. The Breast, 14, 142–150.

    PubMed  CAS  Google Scholar 

  • Shuper, A., Stark, B., Kornreich, L., et al. (2000). Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity. Journal of Child Neurology, 15, 573–580.

    PubMed  CAS  Google Scholar 

  • Silverman, D. H., Dy, C. J., Castellon, S. A., et al. (2006). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Research and Treatment, 103(3), 303–311 September 29.

    PubMed  Google Scholar 

  • Smith, A., Tyrrell, D., Coyle, K., et al. (1988). Effects of interferon alpha on performance in man: a preliminary report. Psychopharmacology, 96, 414–416.

    PubMed  CAS  Google Scholar 

  • Steinherz, L. J., & Yahalom, J. (1993). Cardiac complications of cancer therapy. In V. T. DeVita Jr., S. Hellman, & S. A. Rosenberg (Eds.) Cancer principles and practice of oncology 4th ed. (pp. 2370–2385). Philadephia: J.B. Lippincott Company.

    Google Scholar 

  • Strite, D., Valentine, A. D., & Meyers, C. A. (1997). Manic episodes in two patients treated with interferon alpha. Journal of Neuropsychiatry, 9, 273–276.

    CAS  Google Scholar 

  • Sul, J. K., & DeAngelis, L. M. (2006). Neurologic complications of cancer chemotherapy. Seminar in Oncology, 33, 324–332.

    CAS  Google Scholar 

  • Syrjala, K. L., Dikmen, S., Langer, S. L., Roth-Roemer, S., & Abrams, J. R. (2004). Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood, 104, 3386–3392.

    PubMed  CAS  Google Scholar 

  • Taphoorn, M. J. B., & Klein, M. (2004). Cognitive deficits in adult patients with brain tumors. Lancet Neurology, 3, 159–168.

    PubMed  Google Scholar 

  • Tsavaris, N., Kosmas, C., Vadiaka, M., et al. (2002). Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. British Journal of Cancer, 87, 21–27.

    PubMed  CAS  Google Scholar 

  • Valentine, A. D., & Meyers, C. A. (2005). Neurobehavioral effects of interferon therapy. Current Psychiatry Reports, 7, 391–395.

    PubMed  Google Scholar 

  • Valentine, A. D., Meyers, C. A., Kling, M. A., et al. (1998). Mood and cognitive side effects of interferon-a therapy. Seminar Oncology, 25, 39–47.

    CAS  Google Scholar 

  • Valentine, A. D., Meyers, C. A., & Talpaz, M. (1995). Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Investigation, 13, 561–566.

    PubMed  CAS  Google Scholar 

  • Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2007). Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Annals of Oncology, 19(4), 623–629.

    PubMed  Google Scholar 

  • Wefel, J. S., Lenzi, R., Theriault, R., et al. (2004a). “Chemobrain” in breast cancer? A prologue. Cancer, 101, 466–475.

    PubMed  Google Scholar 

  • Wefel, J. S., Lenzi, R., Theriault, R., et al. (2004b). The cognitive sequelae of standard dose adjuvant chemotherapy in women with breast cancer: results of a prospective, randomized, longitudinal trial. Cancer, 100, 2292–2299.

    PubMed  CAS  Google Scholar 

  • Wefel, J. S., & Meyers, C. A. (2005). Cancer as a risk factor for dementia: a house built on shifting sand. Journal of the National Cancer Institute, 97, 788–789.

    Article  PubMed  Google Scholar 

  • Weiss, R. B., & Vogelzang, N. J. (1993). Miscellaneous toxicities. In V.T. DeVita Jr., S. Hellman, & S.A. Rosenberg (Eds.) Cancer principles and practice of oncology 4th ed. (pp. 2349–2358). Philadelphia: J.B. Lippincott Company.

    Google Scholar 

  • Wilking, N., Appelgren, L.-E., Carlstrom, K., Pousette, A., & Theve, N. O. (1982). The distribution and metabolism of 14C-labelled tamoxifen in spayed female mice. Acta Pharmacologica et Toxicologica (Copenhagen), 50, 161–168.

    CAS  Google Scholar 

  • Wood, L. J., Nail, L. M., Gilster, A., et al. (2006). Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncology Nursing Forum, 33, 535–542.

    PubMed  Google Scholar 

  • Yaffe, K., Sawaya, G., Lieberburg, I., et al. (1998). Estrogen therapy in postmenopausal women effects of cognitive function and dementia. Journal of the American Medical Association, 279, 688–695.

    PubMed  CAS  Google Scholar 

  • Yoshikawa, E., Matsuoka, Y., Inagaki, M., et al. (2005). No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Research and Treatment, 92, 81–84.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuro-Oncology, Section of Neuropsychology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 431, Houston, TX, 77030-4009, USA

    Jeffrey S. Wefel, Mariana E. Witgert & Christina A. Meyers

Authors
  1. Jeffrey S. Wefel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariana E. Witgert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christina A. Meyers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey S. Wefel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wefel, J.S., Witgert, M.E. & Meyers, C.A. Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy. Neuropsychol Rev 18, 121–131 (2008). https://doi.org/10.1007/s11065-008-9058-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11065-008-9058-x

Keywords

Search

Navigation